Comment: Ribociclib for breast cancer

Share :
Published: 10 Oct 2016
Views: 2479
Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium

Dr De Azambuja meets with ecancertv at ESMO 2016 to review abstracts presented at the conference, beginning with that of Dr Hortobagyi on ribociclib for breast cancer.

For more on this topic, please read the associated news story or watch the interview with Dr Hortobagyi. A video of the press conference can also be found here.

ecancer's filming at ESMO 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.